Sastasundar Ventures Limited (SASTASUNDR) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.031x

Based on the latest financial reports, Sastasundar Ventures Limited (SASTASUNDR) has a cash flow conversion efficiency ratio of -0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-271.35 Million ≈ $-2.93 Million USD) by net assets (Rs8.76 Billion ≈ $94.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sastasundar Ventures Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sastasundar Ventures Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Sastasundar Ventures Limited for a breakdown of total debt and financial obligations.

Sastasundar Ventures Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sastasundar Ventures Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
flyExclusive, Inc.
NYSE MKT:FLYX
-0.202x
Icon Group
TA:ICON
-0.040x
Swift Haulage Bhd
KLSE:5303
0.048x
Estika Tata Tiara Tbk PT
JK:BEEF
-1.084x
China Container Terminal Corp
TW:2613
0.068x
E & M Computing Ltd
TA:EMCO
0.118x
Smiths Group PLC
LSE:SMIN
0.100x
Meridia Real Estate III Socimi SA
MC:YMRE
0.044x

Annual Cash Flow Conversion Efficiency for Sastasundar Ventures Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sastasundar Ventures Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see SASTASUNDR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs8.65 Billion
≈ $93.50 Million
Rs-173.09 Million
≈ $-1.87 Million
-0.020x -152.43%
2024-03-31 Rs10.00 Billion
≈ $108.10 Million
Rs381.65 Million
≈ $4.13 Million
0.038x +133.88%
2023-03-31 Rs9.94 Billion
≈ $107.45 Million
Rs-1.12 Billion
≈ $-12.11 Million
-0.113x +34.31%
2022-03-31 Rs12.07 Billion
≈ $130.58 Million
Rs-2.07 Billion
≈ $-22.40 Million
-0.172x -28.99%
2021-03-31 Rs2.29 Billion
≈ $24.81 Million
Rs-305.08 Million
≈ $-3.30 Million
-0.133x +63.75%
2020-03-31 Rs2.46 Billion
≈ $26.63 Million
Rs-903.44 Million
≈ $-9.77 Million
-0.367x -144.83%
2019-03-31 Rs2.00 Billion
≈ $21.62 Million
Rs-299.63 Million
≈ $-3.24 Million
-0.150x +37.56%
2018-03-31 Rs2.03 Billion
≈ $21.99 Million
Rs-488.15 Million
≈ $-5.28 Million
-0.240x -2391.59%
2017-03-31 Rs1.95 Billion
≈ $21.13 Million
Rs-18.82 Million
≈ $-203.56K
-0.010x +82.38%
2016-03-31 Rs2.18 Billion
≈ $23.62 Million
Rs-119.44 Million
≈ $-1.29 Million
-0.055x -17.60%
2015-03-31 Rs2.55 Billion
≈ $27.57 Million
Rs-118.56 Million
≈ $-1.28 Million
-0.046x -135.20%
2014-03-31 Rs2.70 Billion
≈ $29.22 Million
Rs357.03 Million
≈ $3.86 Million
0.132x -4.15%
2013-03-31 Rs2.77 Billion
≈ $29.91 Million
Rs381.24 Million
≈ $4.12 Million
0.138x +1213.19%
2012-03-31 Rs2.68 Billion
≈ $29.01 Million
Rs-33.22 Million
≈ $-359.25K
-0.012x +97.34%
2011-03-31 Rs2.58 Billion
≈ $27.89 Million
Rs-1.20 Billion
≈ $-13.00 Million
-0.466x -444.15%
2010-03-31 Rs925.05 Million
≈ $10.00 Million
Rs125.26 Million
≈ $1.35 Million
0.135x -71.33%
2009-03-31 Rs783.38 Million
≈ $8.47 Million
Rs369.96 Million
≈ $4.00 Million
0.472x +234.60%
2008-03-31 Rs704.70 Million
≈ $7.62 Million
Rs-247.24 Million
≈ $-2.67 Million
-0.351x -181.04%
2007-03-31 Rs248.41 Million
≈ $2.69 Million
Rs107.55 Million
≈ $1.16 Million
0.433x --

About Sastasundar Ventures Limited

NSE:SASTASUNDR India Pharmaceutical Retailers
Market Cap
$96.93 Million
Rs8.96 Billion INR
Market Cap Rank
#19292 Global
#1031 in India
Share Price
Rs281.75
Change (1 day)
-0.30%
52-Week Range
Rs245.50 - Rs329.95
All Time High
Rs562.00
About

Sastasundar Ventures Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services and Healthcare Network segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology and marketing of healthcare and OTC products through e-commerce portal. The company also pro… Read more